$BLUE News Article - bluebird bio Presents Long-Te
Post# of 14
(Total Views: 233)
Posted On: 06/14/2019 8:25:43 AM
$BLUE News Article - bluebird bio Presents Long-Term Efficacy and Safety Data from Clinical Studies of LentiGlobin Gene Therapy for Transfusion-Dependent ?-Thalassemia (TDT) at 24th European Hematology Association (EHA) Congress https://marketwirenews.com/news-releases/blue...56318.html
(0)
(0)Bluebird Bio Inc. (BLUE) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼